Cigna and Centene were among a dozen companies that appeared on the initial JPM agenda that have bowed out of the conference.

Duke neuroscientist Kafui Dzirasa wants nothing less than to reengineer the brain’s electrical patterns to treat anxiety, ...

This amounts to one of the most significant federal government investments in the behavioral health sector in history. For ...

Asian American populations, particularly when broken down into ethnic groups, have allergy health outcomes that are distinct ...

LONDON — Seeking to build up its cancer business, GSK said Monday it is buying the privately held U.S. biotech IDRx for $1 ...

The Biden administration’s final regulation affecting the Medicare Advantage industry would come with a much lighter touch ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

Documents show Robert F. Kennedy Jr. invested in biotech companies and consulted on health care — interests he might have to ...

The changes reflect “a cultural shift” around obesity medications, said Diana Zuckerman, president of the nonprofit National ...

Studies have linked early deaths and asthma exacerbations to chronic exposure to particulate matter in wildfire smoke.

Patrizia Cavazzoni, leader of the FDA's Center for Drug Evaluation and Research, is leaving the agency on Jan. 18.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.